Zbigniew Zasłona
Dr. Zbigniew Zasłona currently serves as Chief Scientific Officer at Molecure. He also manages the Department of Biology. He obtained his PhD in 2010 at the University of Giessen and the Marburg Lung Center in Germany, studying the mechanisms that modulate innate immunity in the context of pneumonia. He then undertook a postdoctoral fellowship at the University of Michigan in the USA, where he focused on pharmacological studies of GPCR receptors, in particular lipid mediators of inflammation. From 2015 to October 2020, he was a research fellow at Trinity College Dublin (Ireland) in the Department of Biochemistry and Immunology, as well as a Senior Investigator at the UK biotechnology company Sitryx (which in March 2020 entered into a $1 bln collaboration and license agreementacquired by Lillywith Eli Lilly), where he was responsible for anti-inflammatory drug development programs. Dr. Zasłona is a recognized international expert in the field of inflammatory processes and lung diseases and is repeatedly invited to lecture at leading international scientific conferences.